1-3 of 3
Miles W. Carroll
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Vaccination of Colorectal Cancer Patients with Modified Vaccinia Ankara Encoding the Tumor Antigen 5T4 (TroVax) Given Alongside Chemotherapy Induces Potent Immune Responses

Free
Richard Harrop, Noel Drury, William Shingler, Priscilla Chikoti, Irina Redchenko, Miles W. Carroll, Susan M. Kingsman, Stuart Naylor, Alan Melcher, Joanna Nicholls, Harpreet Wassan, Nagy Habib, Alan Anthoney
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (15): 4487–4494.
https://doi.org/10.1158/1078-0432.CCR-07-0704
Published: 01 August 2007
View article titled, Vaccination of Colorectal Cancer Patients with Modified Vaccinia Ankara Encoding the Tumor Antigen 5T4 (TroVax) Given Alongside Chemotherapy Induces Potent Immune Responses
Open the PDF for Vaccination of Colorectal Cancer Patients with Modified Vaccinia Ankara Encoding the Tumor Antigen 5T4 (TroVax) Given Alongside Chemotherapy Induces Potent Immune Responses in another window
Journal Articles

Vaccination of Colorectal Cancer Patients with Modified Vaccinia Ankara Delivering the Tumor Antigen 5T4 (TroVax) Induces Immune Responses which Correlate with Disease Control: A Phase I/II Trial

Free
Richard Harrop, Noel Connolly, Irina Redchenko, Juan Valle, Mark Saunders, Matthew G. Ryan, Kevin A. Myers, Noel Drury, Susan M. Kingsman, Robert E. Hawkins, Miles W. Carroll
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (11): 3416–3424.
https://doi.org/10.1158/1078-0432.CCR-05-2732
Published: 01 June 2006
View article titled, Vaccination of Colorectal Cancer Patients with Modified Vaccinia Ankara Delivering the Tumor Antigen 5T4 (TroVax) Induces Immune Responses which Correlate with Disease Control: A Phase I/II Trial
Open the PDF for Vaccination of Colorectal Cancer Patients with Modified Vaccinia Ankara Delivering the Tumor Antigen 5T4 (TroVax) Induces Immune Responses which Correlate with Disease Control: A Phase I/II Trial in another window
Journal Articles

Phase I Study of MetXia-P450 Gene Therapy and Oral Cyclophosphamide for Patients with Advanced Breast Cancer or Melanoma

Free
Jeremy P. Braybrooke, Andrew Slade, Gael Deplanque, Richard Harrop, Srinivasan Madhusudan, Martin D. Forster, Rachel Gibson, Andreas Makris, Denis C. Talbot, Jan Steiner, Linda White, On Kan, Stuart Naylor, Miles W. Carroll, Sue M. Kingsman, Adrian L. Harris
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (4): 1512–1520.
https://doi.org/10.1158/1078-0432.CCR-04-0155
Published: 02 March 2005
View article titled, Phase I Study of MetXia-P450 Gene Therapy and Oral Cyclophosphamide for Patients with Advanced Breast Cancer or Melanoma
Open the PDF for Phase I Study of MetXia-P450 Gene Therapy and Oral Cyclophosphamide for Patients with Advanced Breast Cancer or Melanoma in another window